Table 3. Overview of research works on fusion of pathomics with radiomics.
References | Aims | Approach | Data used | Results | |
MRI, magnetic resonance imaging; H&E, hematoxylin and eosin; AUC, area under the curve; MRF, magnetic resonance fingerprinting; ADC, apparent diffusion coefficient; ROI, region of interest; CT, computed tomography; NPC, nasopharyngeal cancer; NSCLC, non-small cell lung cancer; nCRT, neoadjuvant chemoradiotherapy; SVM, support vector machine; GBM, glioblastoma; TCIA, The Cancer Imaging Archive; TCGA, The Cancer Genomic Atlas. | |||||
Penzias
et al. (29) |
Identify morphologic basis of radiomic features for prostate cancer risk stratification | Radiomic features from T2W MRI that were associated with low- and high-risk prostate cancer were identified, pathomic features that were best correlated with these features were explored | A single institution cohort of 36 patient studies was used with T2W MRI, post-surgical H&E slides | Gabor features on T2W MRI performance (AUC=0.69) and gland lumen shape features (AUC=0.75) resulted in best classification performance | |
Shiradkar
et al. (30) |
Establish the morphologic basis of MR fingerprinting values on the prostate. | Co-registration of whole mount pathology with MRI, MRF followed by correlation of tissue compartments with MR measurements within prostate cancer, prostatitis and normal prostate ROI | A set of 14 patient studies who underwent MRI, MRF scans followed by radical prostatectomy | Tissue compartments of epithelium, lumen and stroma were significantly correlated with T1, T2 MRF, ADC values (P<0.05) | |
Alvarez-Jimenez
et al. (28) |
Association between radiomic and pathomic features that distinguish adenocarcinoma and squamous cell carcinoma | Pathomic features from digitized H&E slides of lung cancer; radiomic features from lung cancer CT scans; Cross scale associations were computed between radiomic and pathomic features to compare with individual feature classes | N=171 pathology studies, n=101 lung CT studies acquired from publicly available databases. | Cross-scale associated features resulted in better discrimination (AUC=0.78) of NSCLC subtypes compared to using individual feature classes | |
Zhang
et al. (34) |
A prognostic nomogram integrating radiomics and pathology signature to prognosticate NPC | Radiomics from MRI images are combined with a pathomic signature obtained from a deep learning model along with clinical factors to build a multi-scale prognostic nomogram for nasopharyngeal cancer | N=220 NPC patients were divided into n=132 for training, n=88 for internal and external validation. | Multi-scale nomogram resulted in an improved predictor of survival (C-index 0.82 vs. 0.73) compared with clinical model and individual signatures. | |
Vaidya
et al. (33) |
Integrating radiomic and pathomic signatures of NSCLC to predict cancer recurrence | Radiomic features from ROIs on lung CT were combined with pathomic eatures from H&E slides of resected tissue to build an integrated supervised machine learning classifier. | 50 NSCLC patients were used for training and 43 patients for external validation | The combined classifier resulted in higher AUC=0.78 compared to radiomic (AUC=0.74) and pathomic classifier (AUC=0.67) alone | |
Braman
et al. (36) |
Deep learning prognostic model for gliomas integrating radiology, pathology, genomics and clinical data | Deep learning model where each modality embeddings are combined via attention gated tensor fusion. A multimodal orthogonalization loss is presented to maximize information from each modality so they are complementary. | 176 patients witn T1w and T2w-FLAIR sequences annotated by 7 radiologists, H& slides and DNA sequencing info | Presented model results in C-index of 0.788±0.067, significantly outperforming (P=0.023) the best performing unimodal (C-index of 0.718±0.064) | |
Shao
et al. (32) |
Integrating radiological and pathological information on pre-treatment info to predict pathological response in rectal cancer | Computational features were derived from rectal pre-treatment MRI and digitized H&E slides, combined to create a radiopathomic signature (RPS) to predict treatment response | N=981 patients who received nCRT along with pretreatment MRI and biopsy whole slide images. | RPS resulted in AUC of 0.84−0.98 at each grade of pathological response with significantly higher performance compared to without integration. | |
Rathore
et al. (31) |
Integrating radiomic and pathomic features for prognosis of GBM | Radoimic features from T1, T1-Gd, T2, T2-FLAIR, were combined with pathomic s of H&E slides to build a SVM classifier for differentiating long and short term survivors | N=107 GBM patients with MRI and pathology images obtained from TCIA and TCGA | AUC=0.74, 0.76 and 0.8 for radiomics, pathomics and combined model in predicting survival outcome |